NICHOLAS MAXWELL: Open Payments
NPI 1194211144 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,637 in 146 payments from 16 companies in 2025. Trend: 2023 $2,033 · 2024 $2,337 · 2025 $2,637
Food & beverage: $2,637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $666 |
| Janssen Biotech, Inc. | 20 | $387 |
| Arcutis Biotherapeutics, Inc. | 11 | $270 |
| Novartis Pharmaceuticals Corporation | 10 | $237 |
| E.R. Squibb & Sons, L.L.C. | 9 | $211 |
| Lilly USA, LLC | 16 | $210 |
| UCB, Inc. | 12 | $174 |
| PFIZER INC. | 9 | $164 |
| Amgen Inc. | 5 | $107 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $52 |
Products named: TREMFYA, RINVOQ, Zoryve, SKYRIZI, Sotyktu, TALTZ, Bimzelx, CIBINQO.
Industry payments across MO — which companies pay providers there.
